المؤلفون: Laura Maffei, Maria Cantonetti, Raffaele Lentini, M. Christina Cox-Froncillo, Maurizio Tribalto, Giuseppe Papa, Mario Masi, Paolo Giudiceandrea, Sergio Amadori

المصدر: Cancer Genetics and Cytogenetics. 84:15-18

مصطلحات موضوعية: Myeloid, Male, Oncology, Cancer Research, medicine.medical_specialty, Settore MED/06 - Oncologia Medica, medicine.medical_treatment, Alpha interferon, Biology, metaphase, Fluorescence, chronic myeloid leukemia, oncogene, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, Genetics, medicine, Humans, priority journal MeSH: Chromosome Aberrations, human, Chronic, EMTREE drug terms: recombinant alpha2a interferon EMTREE medical terms: article, Non-U.S. Gov't, fluorescence in situ hybridization, Molecular Biology, In Situ Hybridization, Fluorescence, In Situ Hybridization, Interferon alfa, Chromosome Aberrations, clinical article, Chemotherapy, Leukemia, ABL, human cell, chromosome analysis, breakpoint cluster region, Cytogenetics, Interferon-alpha, Myeloid leukemia, interphase, female, Cytokine, cancer regression, Immunology, Support, Settore MED/15 - Malattie del Sangue, male, Female, Human, Leukemia, Myeloid, Chronic, Support, Non-U.S. Gov't, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b4714fedc92e5aeac5b1e269a05b8f
https://doi.org/10.1016/0165-4608(95)00029-1